OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Psychiatry is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression	316
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia	303
Psychedelics and Psychedelic-Assisted Psychotherapy	288
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation	271
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial	229
The Critical Relationship Between Anxiety and Depression	216
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review	204
Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies	192
Mental Health Response to the COVID-19 Outbreak in China	183
Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation	179
Identification of Common Neural Circuit Disruptions in Emotional Processing Across Psychiatric Disorders	178
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia	135
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings	130
Reduction in Mental Health Treatment Utilization Among Transgender Individuals After Gender-Affirming Surgeries: A Total Population Study	127
Hormonal Treatments for Major Depressive Disorder: State of the Art	121
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder	121
From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States	120
An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression	120
Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups	116
Neuroimaging Biomarkers in Schizophrenia	114
Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank	106
Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD	105
A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic Disorder	95
Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19	93
A Brain-Centric Model of Suicidal Behavior	92

The Overlapping Neurobiology of Induced and Pathological Anxiety: A Meta-Analysis of Functional Neural Activation	88
Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder	88
Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity	85
Association of Prenatal Alcohol Exposure With Psychological, Behavioral, and Neurodevelopmental Outcomes in Children From the Adolescent Brain Cognitive Development Study	84
The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?	83
Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia	80
Toward Circuit Mechanisms of Pathophysiology in Depression	76
The Impact of COVID-19 on Individuals With Intellectual and Developmental Disabilities: Clinical and Scientific Priorities	75
Psychotherapy at a Distance	75
Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies	72
The Mental Health Effects of COVID-19 on Health Care Providers in China	70
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study	68
Autism Spectrum Disorder Genetics and the Search for Pathological Mechanisms	67
Genome-Wide Association Study of Suicide Death and Polygenic Prediction of Clinical Antecedents	62
A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants	60
Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice	58
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial	57
Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development	56
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts	56
Alcohol Use Disorder and Risk of Suicide in a Swedish Population-Based Cohort	55
Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness	54
Examining the Reach of Smartphone Apps for Depression and Anxiety	54
Association Between Ambient Air Pollution and Daily Hospital Admissions for Depression in 75 Chinese Cities	54
Large-Scale Functional Brain Network Architecture Changes Associated With Trauma-Related Dissociation	54
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis	54
Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies	51
Age Differences in the Neural Correlates of Anxiety Disorders: An fMRI Study of Response to Learned Threat	51
Sleep Onset Problems and Subcortical Development in Infants Later Diagnosed With Autism Spectrum Disorder	51